- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-8722
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Anti-claudin 18.2 antibody as new targeted therapy for advanced gastric cancer ; volume:10 ; number:1 ; day:12 ; month:5 ; year:2017 ; pages:1-5 ; date:12.2017
Journal of hematology & oncology ; 10, Heft 1 (12.5.2017), 1-5, 12.2017
- Keyword
-
Krebs
Onkologie
- Creator
-
Singh, Prabhsimranjot
- Contributor
-
Toom, Sudhamshi
Huang, Yiwu
SpringerLink (Online service)
- DOI
-
10.1186/s13045-017-0473-4
- URN
-
urn:nbn:de:1111-20170522792
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:22 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Singh, Prabhsimranjot
- Toom, Sudhamshi
- Huang, Yiwu
- SpringerLink (Online service)
Other Objects (12)
Heterogeneity of claudin 18.2 expression in metastatic gastric cancer
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
Claudin-18.2 mediated interaction of gastric Cancer cells and Cancer-associated fibroblasts drives tumor progression
Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer
Clinicopathological significance of claudin-4 in gastric carcinoma
Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
Antibody targeting of claudin-1 as a potential colorectal cancer therapy
Targeted therapy in gastric cancer
BRCAA1 antibody- and Her2 antibody-conjugated amphiphilic polymer engineered CdSe/ZnS quantum dots for targeted imaging of gastric cancer
BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer
HAI-178 antibody-conjugated fluorescent magnetic nanoparticles for targeted imaging and simultaneous therapy of gastric cancer
Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study
Heterogeneity of claudin 18.2 expression in metastatic gastric cancer
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
Claudin-18.2 mediated interaction of gastric Cancer cells and Cancer-associated fibroblasts drives tumor progression
Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer
Clinicopathological significance of claudin-4 in gastric carcinoma
Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
Antibody targeting of claudin-1 as a potential colorectal cancer therapy
Targeted therapy in gastric cancer
BRCAA1 antibody- and Her2 antibody-conjugated amphiphilic polymer engineered CdSe/ZnS quantum dots for targeted imaging of gastric cancer
BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer
HAI-178 antibody-conjugated fluorescent magnetic nanoparticles for targeted imaging and simultaneous therapy of gastric cancer
Expression of the potential therapeutic target claudin-18.2 is frequently decreased in gastric cancer: results from a large Caucasian cohort study
Heterogeneity of claudin 18.2 expression in metastatic gastric cancer
Prognostic impact of Claudin 18.2 in gastric and esophageal adenocarcinomas
Claudin-18.2 mediated interaction of gastric Cancer cells and Cancer-associated fibroblasts drives tumor progression
Clinicopathologic features and prognostic value of claudin 18.2 overexpression in patients with resectable gastric cancer
Clinicopathological significance of claudin-4 in gastric carcinoma
Imaging of Claudin-4 in Pancreatic Ductal Adenocarcinoma Using a Radiolabelled Anti-Claudin-4 Monoclonal Antibody
Antibody targeting of claudin-1 as a potential colorectal cancer therapy
Targeted therapy in gastric cancer
BRCAA1 antibody- and Her2 antibody-conjugated amphiphilic polymer engineered CdSe/ZnS quantum dots for targeted imaging of gastric cancer
BRCAA1 monoclonal antibody conjugated fluorescent magnetic nanoparticles for in vivo targeted magnetofluorescent imaging of gastric cancer
HAI-178 antibody-conjugated fluorescent magnetic nanoparticles for targeted imaging and simultaneous therapy of gastric cancer